Daniel Kelly, MD, MHQS
Associate Medical Director, Quality and Outcomes, Department of Pediatrics; Director, Quality and Patient Safety, Division of Medical Critical Care; Intensivist, Division of Medical Critical Care
Assistant Professor of Pediatrics, Harvard Medical School
Image
Daniel Kelly, MD, MHQS
Associate Medical Director, Quality and Outcomes, Department of Pediatrics; Director, Quality and Patient Safety, Division of Medical Critical Care; Intensivist, Division of Medical Critical Care
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
Warren Alpert Medical School of Brown University
2007
Providence
RI
Residency
Pediatrics
New York Presbyterian Hospital/ Weill Cornell Medical Center
2011
New York
NY
Fellowship
Pediatric Critical Care
Boston Children's Hospital
2014
Boston
MA
Fellowship
Transfusion Medicine
Brigham and Women’s Hospital/ Boston Children’s Hospital
2015
Boston
MA
Graduate School
Master of Healthcare Quality and Safety
Harvard Medical School
2022
Boston
MA
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Critical Care Medicine)
American Board of Pathology (Blood Banking/Transfusion Medicine)
Publications
Optimizing High-Flow Nasal Cannula Weaning in Patients With Bronchiolitis. View Abstract
Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fraction. View Abstract
Crossover Trial of Exogenous Ketones on Cardiometabolic Endpoints in Heart Failure With Preserved Ejection Fraction. View Abstract
Diagnostic Stewardship of Endotracheal Aspirate Cultures in Hospitalized Children With Artificial Airways: Expert Consensus Statements From the BrighT STAR (Testing STewardship for Antibiotic Reduction) Respiratory Collaborative. View Abstract
JACC: Basic to Translational Science: Honoring the Top Reviewers of 2024. View Abstract
Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension. View Abstract
Metabolic and Pharmacokinetic Profiling of a Ketone Ester by Background SGLT2 Inhibitor Therapy in HFrEF. View Abstract
Cardiac NAD+ depletion in mice promotes hypertrophic cardiomyopathy and arrhythmias prior to impaired bioenergetics. View Abstract
Targeted Quantitative Plasma Metabolomics Identifies Metabolite Signatures that Distinguish Heart Failure with Reduced and Preserved Ejection Fraction. View Abstract
SGLT2 Inhibitors Act Independently of SGLT2 to Confer Benefit for HFrEF in Mice. View Abstract
Pediatric Intermediate Care Units: A Bridge Between Pediatric Ward and ICU Care. View Abstract
Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension. View Abstract
Sodium-glucose co-transporter 2 Inhibitors Act Independently of SGLT2 to Confer Benefit for Heart Failure with Reduced Ejection Fraction in Mice. View Abstract
Clinical decision support to enhance venous thromboembolism pharmacoprophylaxis prescribing for pediatric inpatients with COVID-19. View Abstract
A Survey of PICU Clinician Practices and Perceptions regarding Respiratory Cultures in the Evaluation of Ventilator-Associated Infections in the BrighT STAR Collaborative. View Abstract
Improving guideline-concordant thromboprophylaxis prescribing for children admitted to hospital with COVID-19. View Abstract
Activated Clotting Times Demonstrate Weak Correlation With Heparin Dosing in Adult Extracorporeal Membrane Oxygenation. View Abstract
How we manage blood product support and coagulation in the adult patient requiring extracorporeal membrane oxygenation. View Abstract
Metric Development for the Multicenter Improving Pediatric Sepsis Outcomes (IPSO) Collaborative. View Abstract
Life-Threatening Hemoptysis in a Pediatric Referral Center. View Abstract
Practice Improvement for Standardized Evaluation and Management of Acute Tracheitis in Mechanically Ventilated Children. View Abstract
Development of a Quality Improvement Learning Collaborative to Improve Pediatric Sepsis Outcomes. View Abstract
Quality Improvement Incorporating a Feedback Loop for Accurate Medication Reconciliation. View Abstract
Effect of platelet storage duration on clinical outcomes and incremental platelet change in critically ill children. View Abstract
Pediatric Plasma and Platelet Transfusions on Extracorporeal Membrane Oxygenation: A Subgroup Analysis of Two Large International Point-Prevalence Studies and the Role of Local Guidelines. View Abstract
International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis. View Abstract
Initiation of Noninvasive Ventilation for Acute Respiratory Failure in a Pediatric Intermediate Care Unit. View Abstract
Effects of ABO Matching of Platelet Transfusions in Critically Ill Children. View Abstract
Platelet Transfusion Practices in Critically Ill Children. View Abstract
Combination Clearance Therapy and Barbiturate Coma for Severe Carbamazepine Overdose. View Abstract
Transfusion-related immunomodulation: review of the literature and implications for pediatric critical illness. View Abstract
Quality improvement program reduces venous thromboembolism in infants and children with long-gap esophageal atresia (LGEA). View Abstract
A multinational study of thromboprophylaxis practice in critically ill children. View Abstract
High incidence of catheter-associated venous thromboembolic events in patients with long gap esophageal atresia treated with the Foker process. View Abstract
Prevalence of clinical hip abnormalities in haemophilia A and B: an analysis of the UDC database. View Abstract
Detecting pediatric delirium: development of a rapid observational assessment tool. View Abstract
Locations